NCT03080597

Brief Summary

The investigators' overall goals are to target (a) pre-exposure prophylaxis (PrEP) uptake by addressing access and acceptability and (b) PrEP adherence among Historically Black Colleges and Universities (HBCU) students.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 15, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

January 31, 2019

Status Verified

March 1, 2018

Enrollment Period

1.6 years

First QC Date

January 17, 2017

Last Update Submit

January 30, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility as measured by the number of times per day that subjects initiate an interaction with PrEP Smart

    As measured by the number of times per day that subjects initiate an interaction with PrEP Smart

    8 weeks

  • Feasibility as measured by the number of times per day that subjects respond to a PrEP Smart prompt

    As measured by the number of times per day that subjects respond to a PrEP Smart prompt

    8 weeks

Secondary Outcomes (3)

  • Acceptability will be assessed during the final laboratory visit with an open ended qualitative interview assessing overall feedback

    8 weeks

  • Acceptability will be assessed by feedback specific to each of the six individual PrEP Smart features

    8 weeks

  • Adherence will be assessed by the number of times that PrEP was taken daily over the 8 week period and the number of times that it was taken outside of a one hour window in which it was prescribed

    8 weeks

Study Arms (1)

Smartphone app condition

EXPERIMENTAL

English-speaking males, between the ages of 18-30, who are enrolled at a HBCU or identify as Black/African American, who are currently prescribed PrEP (Truvada) for HIV Prevention, and owners of either an Android or iOS smartphone, will be asked to use an application on their smart phones called "PrEP Smart".

Device: PrEP Smart app

Interventions

English-speaking males, between the ages of 18-30, who are enrolled at a HBCU or identify as Black/African American, who are currently prescribed PrEP (Truvada) for HIV Prevention, and owners of either an Android or iOS smartphone, will be asked to use an application on their smart phones called "PrEP Smart".an application on their smart phones called "PrEP Smart".

Smartphone app condition

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Enrolled as a student in a Historically Black College or University, OR identify as Black/African American
  • Male
  • Self-report having sex with men in the past 6 months
  • years of age
  • English-speaking
  • Currently prescribed PrEP (Truvada) for HIV prevention
  • Participant has an Android (using v5.x.x or lollipop) or iOS (v6.0) smartphone

You may not qualify if:

  • History of a chronic/significant medical or psychiatric condition that will interfere with study participation
  • Unable to attend sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27705, United States

Location

Study Officials

  • John T Mitchell, Ph.D.

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2017

First Posted

March 15, 2017

Study Start

March 1, 2017

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

January 31, 2019

Record last verified: 2018-03

Locations